Skip to main content

Table 6 Mean values of ICS score of gender, age groups, cancer, breast cancer, colorectal cancer and healthy controls

From: Reliability and validity of a new scale on internal coherence (ICS) of cancer patients

  Internal Coherence Scale Inner Resilience and Coherence Thermo Coherence Self regulation
STUDY 1     
Gender     
Female (71.9%) 36.52 (7.82) 28.67 (6.44) 7.91 (1.53) 4.05 (0.80)
Male (28.1%) 38.84 (7.17) 30.32 (5.91) 7.94 (1.46) 4.25 (0.65)
Individuals     
Healthy controls (SD) 40.12 (5.12) 31.43 (4.48) 8.25 (1.30) 4.27 (0.72)
Cancer (SD) 34.23 (8.68) 26.80 (7.07) 7.60 (1.64) 3.97 (0.78)
p-value * <0.001 <0.001 0.028 0.079
STUDY 2     
Breast cancer group 1 T0 36.12 (7.64) 28.41 (6.54) 7.70 (2.28)  
Breast cancer group 1 T1 34.88 (7.53) 27.29 (6.25) 7.58 (1.97)  
Breast cancer group 1 T2 35.35 (6.38) 27.94 (5.99) 7.41 (1.97)  
Colorectal cancer T0 38.87 (6.49) 30.43 (5.81) 8.30 (1.94)  
Colorectal cancer T1 35.88 (9.36) 28.47 (7.79) 7.12 (2.33)  
Colorectal cancer T2 38.96 (6.75) 32.04 (5.44) 7.48 (2.27)  
p-value T0 vs T1 ** 0.026 0.043 0.020  
p-value T1 vs T2** 0.009 0.008 0.268  
  1. * Exact U-Test (2-side), ** Exact Wilcoxon-Test (1-side) used for pooled breast cancer and colorectal cancer and tests T0 (before chemotherapy) vs. T1 (1–5 days after third chemotherapy cycle) and T1 vs. T2 (4 – 8 weeks after the end of chemotherapy).
  2. Significant differences (p < 0.05) are presented bold.